Non-Perturbative QCD Treatment of High-Energy Hadron-Hadron Scattering

Total cross-sections and logarithmic slopes of the elastic scattering cross-sections for different hadronic processes are calculated in the framework of the model of the stochastic vacuum. The relevant parameters of this model, a correlation length and the gluon condensate, are determined from scattering data, and found to be in very good agreement with values coming from completely different sources of information. A parameter-free relation is given between total cross-sections and slope parameters, which is shown to be remarkably valid up to the highest energies for which data exist.Comment: 60 pages, Heidelberg preprin

Bio-nanotechnology application in wastewater treatment

The nanoparticles have received high interest in the field of medicine and water purification, however, the nanomaterials produced by chemical and physical methods are considered hazardous, expensive, and leave behind harmful substances to the environment. This chapter aimed to focus on green-synthesized nanoparticles and their medical applications. Moreover, the chapter highlighted the applicability of the metallic nanoparticles (MNPs) in the inactivation of microbial cells due to their high surface and small particle size. Modifying nanomaterials produced by green-methods is safe, inexpensive, and easy. Therefore, the control and modification of nanoparticles and their properties were also discussed

Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years

Numbers of Hematopoietic cell transplantation (HCT) in Europe and collaborating countries continues to rise with 48,512 HCT in 43,581 patients, comprising of 19,798 (41%) allogeneic and 28,714 (59%) autologous, reported by 700 centers in 51 countries during 2019. Main indications were myeloid malignancies 10,764 (25%), lymphoid malignancies 27,895 (64%), and nonmalignant disorders 3173 (7%). A marked growth in CAR-T cellular therapies from 151 in 2017 to 1134 patients in 2019 is observed. This year’s analyses focus on changes over 30 years. Since the first survey in 1990 where 143 centers reported 4234 HCT, the number has increased to 700 centers and 48,512 HCT. Transplants were reported in 20 countries in 1990, and 51, 30 years later. More than 800,000 HCT in 715,000 patients were reported overall. Next to the massive expansion of HCT technology, most notable developments include the success of unrelated donor and haploidentical HCT, an increase followed by decrease in the number of cord blood transplants, use of reduced intensity HCT in older patients, and the phenomenal rise in cellular therapy. This annual report of the European Society for Blood and Marrow Transplantation (EBMT) reflects current activity and highlights important trends vital for health care planning

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

For over two decades, the EBMT has updated recommendations on indications for haematopoietic cell transplantation (HCT) practice based on clinical and scientific developments in the field. This is the eighth special EBMT report on the indications for HCT for haematological diseases, solid tumours and immune disorders. Our aim is to provide general guidance on HCT indications according to prevailing clinical practice in EBMT countries and centres. In order to inform patient decisions, these recommendations must be considered in conjunction with the risk of the disease, risk of HCT procedure and non-transplant strategies, including evolving cellular therapies. HCT techniques are constantly evolving and we make no specific recommendations, but encourage harmonisation of practice, where possible, to ensure experience across indications can be meaningfully aggregated via registry outputs. We also recommend working according to JACIE accreditation standards to maintain quality in clinical and laboratory components of practice, including benchmarking of survival outcomes. Since the last edition, the COVID-19 pandemic has affected clinical decision making and activity across indications. Although the full impact of the pandemic is yet to be determined, we recommend that decision making across indications is delivered with ongoing reference to EBMT and national COVID-19 guidance, in accordance with current local conditions

Evolutionary Computation, Optimization and Learning Algorithms for Data Science

A large number of engineering, science and computational problems have yet to be solved in a computationally efficient way. One of the emerging challenges is how evolving technologies grow towards autonomy and intelligent decision making. This leads to collection of large amounts of data from various sensing and measurement technologies, e.g., cameras, smart phones, health sensors, smart electricity meters, and environment sensors. Hence, it is imperative to develop efficient algorithms for generation, analysis, classification, and illustration of data. Meanwhile, data is structured purposefully through different representations, such as large-scale networks and graphs. We focus on data science as a crucial area, specifically focusing on a curse of dimensionality (CoD) which is due to the large amount of generated/sensed/collected data. This motivates researchers to think about optimization and to apply nature-inspired algorithms, such as evolutionary algorithms (EAs) to solve optimization problems. Although these algorithms look un-deterministic, they are robust enough to reach an optimal solution. Researchers do not adopt evolutionary algorithms unless they face a problem which is suffering from placement in local optimal solution, rather than global optimal solution. In this chapter, we first develop a clear and formal definition of the CoD problem, next we focus on feature extraction techniques and categories, then we provide a general overview of meta-heuristic algorithms, its terminology, and desirable properties of evolutionary algorithms

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

Coronavirus disease-19 (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), represents one of the biggest challenges of 21st century, threatening public health around the globe. Increasing age and presence of co-morbidities are reported risk factors for severe disease and mortality, along with autoimmune diseases (ADs) and immunosuppressive treatments such as haematopoietic stem cell transplantation (HSCT), which are also associated with adverse outcomes. We review the impact of the pandemic on specific groups of patients with neurological, rheumatological, and gastroenterological indications, along with the challenges delivering HSCT in adult and pediatric populations. Moving forward, we developed consensus-based guidelines and recommendations for best practice and quality of patient care in order to support clinicians, scientists, and their multidisciplinary teams, as well as patients and their carers. These guidelines aim to support national and international organizations related to autoimmune diseases and local clinical teams delivering HSCT. Areas of unmet need and future research questions are also highlighted. The waves of the COVID-19 pandemic are predicted to be followed by an "endemic" phase and therefore an ongoing risk within a "new normality". These recommendations reflect currently available evidence, coupled with expert opinion, and will be revised according to necessary modifications in practice.Pathophysiology and treatment of rheumatic disease

In situ mechanical testing of nuclear graphite at elevated temperatures: Synchrotron x-ray tomography, neutron diffraction and Raman scattering

High temperature in situ tests of Gilsocarbon polygranular nuclear graphite have investigated the microstructure's deformation at two length scales. At the µm-scale, in situ bending tests observed by synchrotron radiation x-ray computed micro-tomography evaluated the bulk mechanical properties of flexural strength and fracture toughness and observed crack propagation at temperatures up to 1000°C; at the atomic-scale, neutron diffraction data correlated the lattice strain with bulk stress at temperatures up to 850°C. Raman scattering observations at temperatures up to 800°C showed the change of micro-scale residual strains. Gilsocarbon graphite was found to have a higher strength and fracture toughness with increased temperature. The mechanism leading to this behaviour has been attributed to the relaxation of residual strains